Literature DB >> 9782502

Mechanism of isoniazid uptake in Mycobacterium tuberculosis.

Fabienne Bardou1, Catherine Raynaud1, Corinne Ramos1, Marie Antoinette Lanéelle1, Gilbert Lanŕelle1.   

Abstract

Initial transport kinetics of isoniazid (INH) and its uptake at the plateau were studied in Mycobacterium tuberculosis H37Rv under various experimental conditions. The initial uptake velocity increased linearly with INH concentration from 2 x 10(-6) M to 10(-2) M. It was modified neither by addition of a protonophore that abolished proline transport, nor following ATP depletion by arsenate, which inhibited glycerol uptake, two transport processes taken as controls for secondary active transport and facilitated diffusion, respectively. Microaerobiosis or low temperature (4 degrees C) were without effect on initial uptake. It is thus likely that INH transport in M. tuberculosis proceeds by a passive diffusion mechanism, and that catalase-peroxidase (KatG) is not involved in the actual transport. However, conditions inhibiting KatG activity (high INH concentration, microaerobiosis, low temperature) decrease cell radioactivity at the uptake plateau. It is proposed that INH transport occurs by passive diffusion. KatG is involved only in the intracellular accumulation of oxidized derivatives of INH, especially of isonicotinic acid, which is trapped inside cells in its ionized form. This model explains observed and previously known characteristics of the accumulation of radioactivity in the presence of [14C]INH for various species and strains of mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9782502     DOI: 10.1099/00221287-144-9-2539

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  16 in total

1.  Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.

Authors:  Rosilene Fressatti Cardoso; Robert C Cooksey; Glenn P Morlock; Patricia Barco; Leticia Cecon; Francisco Forestiero; Clarice Q F Leite; Daisy N Sato; Maria de Lourdes Shikama; Elsa M Mamizuka; Rosario D C Hirata; Mario H Hirata
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling.

Authors:  Griselda Tudó; Ken Laing; Denis A Mitchison; Philip D Butcher; Simon J Waddell
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

3.  Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.

Authors:  Min Zhang; Jun Yue; Yan-Ping Yang; Hong-Mei Zhang; Jian-Qiang Lei; Rui-Liang Jin; Xue-Lian Zhang; Hong-Hai Wang
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Structure Dependence of Pyridine and Benzene Derivatives on Interactions with Model Membranes.

Authors:  Benjamin J Peters; Cameron Van Cleave; Allison A Haase; John Peter B Hough; Keisha A Giffen-Kent; Gabriel M Cardiff; Audra G Sostarecz; Dean C Crick; Debbie C Crans
Journal:  Langmuir       Date:  2018-07-19       Impact factor: 3.882

5.  Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis.

Authors:  Joachim Stephan; Claudia Mailaender; Gilles Etienne; Mamadou Daffé; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis.

Authors:  Xia Xu; Catherine Vilchèze; Yossef Av-Gay; Anaximandro Gómez-Velasco; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

7.  A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.

Authors:  Kamunkhwala Gausi; Elisa H Ignatius; Xin Sun; Soyeon Kim; Laura Moran; Lubbe Wiesner; Florian von Groote-Bidlingmaier; Richard Hafner; Kathleen Donahue; Naadira Vanker; Susan L Rosenkranz; Susan Swindells; Andreas H Diacon; Eric L Nuermberger; Kelly E Dooley; Paolo Denti
Journal:  Am J Respir Crit Care Med       Date:  2021-12-01       Impact factor: 21.405

Review 8.  Reappraising the use of β-lactams to treat tuberculosis.

Authors:  Sebastian G Kurz; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

9.  Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.

Authors:  Srinivas V Ramaswamy; Robert Reich; Shu-Jun Dou; Linda Jasperse; Xi Pan; Audrey Wanger; Teresa Quitugua; Edward A Graviss
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  The role of transport mechanisms in mycobacterium tuberculosis drug resistance and tolerance.

Authors:  Jansy Passiflora Sarathy; Véronique Dartois; Edmund Jon Deoon Lee
Journal:  Pharmaceuticals (Basel)       Date:  2012-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.